Medication Monitor



Generic Name (Trade Name—Company)
Notes
July 19, 2011

Pramlintide in vials

(Symlin—Amylin)
Patients should be switched to pens

Amylin announced that it will stop manufacturing Symlin vials, but will continue to market the SymlinPen pen-injector delivery system. Pharmacists are advised to continue dispensing the existing stock of the vials until inventories have been depleted, and health providers are advised to start transitioning patients over to the pens. It is important to note that when switching patients from the vial to the pen, doses will need to be converted from units to mcg as follows: 2.5 units = 15 mcg, 5 units = 30 mcg, 7.5 units = 45 mcg, 10 units = 60 mcg, and 20 units = 120 mcg.